“Global Growth in Cardiovascular Diseases (CVD) Incidence”
Cardiovascular diseases are a leading cause of death worldwide. According to the World Health Organization (WHO), CVDs are responsible for approximately 32% of global deaths, primarily driven by hypertension, coronary artery disease, heart failure, and arrhythmias. The global population is aging, particularly in regions like North America, Europe, and Japan, which are seeing a rise in age-related cardiovascular conditions. This demographic shift is propelling demand for cardiovascular drugs, especially those based on small molecule APIs. As a result, the market for these APIs is expanding, with increased emphasis on developing innovative therapies, including generics, combination therapies, and precision medicine tailored to specific patient needs.
